361Firm Briefing "Shock Averted, Now What?" & Deep Dive on "2H 2025 Tech Investing" July 1, 2025

361Firm Briefing "Shock Averted, Now What?" & Deep Dive on "2H 2025 Tech Investing" July 1, 2025 Transcript: https://361.pub/july1briefing SUMMARY The meeting discussed the current state of the global economy and tech investing. Stephen Burke highlighted a 19% S&P 500 drop and the impact of de-escalation between Israel and Iran. He emphasized the importance of Fed independence and the potential for rate cuts. Rafiq Ahmed from Chicago Ventures discussed Midwest investment opportunities, noting a 65% valuation advantage over the West Coast. Julia Monfrini from Pace Healthcare emphasized the potential for outsized returns in healthcare tech, citing a 2.53x DPI for her fund. Nelson Stacks from Waveguide shared insights on out-licensing technology from universities. The panel also explored strategies for navigating the current venture capital environment. The meeting discussed the healthcare sector's shorter investment timelines compared to traditional tech ventures, with biotech funds completing phases in under five years. Rafiq Ahmed highlighted the growing use of DAFs in venture and PE investments. J.P. Keating shared a report on the US VC market, emphasizing Midwest trends. Spencer Walker noted MIT and Stanford's success in tech transfer. Parth Vakil praised Austin's tech innovation. The discussion also covered the challenges of secondary markets, IPO dynamics, and effective portfolio management. Upcoming events were planned in Newport, New York, Hamptons, London, and various international locations, with a focus on tax updates and manufacturing hubs.